| CAS ID: | 1629249-33-7 |
| Molecular Formula: | C29H38ClN5O2 |
| Molecular Weight: | 524.1 g/mol |
| Monoisotopic Mass: | 523.271 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H37N5O2.ClH/c1-20-15-21(2)34(32-20)27-7-3-5-24(16-27)25(17-28(35)36)19-33-14-12-22(18-33)8-10-26-11-9-23-6-4-13-30-29(23)31-26;/h3,5,7,9,11,15-16,22,25H,4,6,8,10,12-14,17-19H2,1-2H3,(H,30,31)(H,35,36);1H/t22-,25-;/m0./s1 | See All |
| InChI Key: | GCZLVFRSWWTRPH-YSCHMLPRSA-N | |
| Smiles: | CC1=CC(=NN1C2=CC=CC(=C2)C(CC(=O)O)CN3CCC(C3)CCC4=NC5=C(CCCN5)C=C4)C.Cl | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02612051 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | November 23, 2015 | Last Verified | May 1, 2017 |
| Sponsor | GlaxoSmithKline | ||
Trial Record 2
| ClinicalTrial ID | NCT03069989 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1 | Status | Terminated |
| First Received | March 3, 2017 | Last Verified | January 8, 2019 |
| Sponsor | GlaxoSmithKline | ||
| PubChem: | 126970667 |
| ChEMBL: |